Injecto A/S: Financial statements 2024
CVR: 38729888
Source: annual report 2024, Danish Business Authority
01/09/2023 – 31/08/2024
Injecto A/S (CVR 38729888) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -2,866,909 and a net result of DKK -2,982,525 compared with DKK -2,626,586 the year before. Equity in the 2024 report amounted to DKK 399,240. The solvency ratio was 14.1%.
- Gross Profit
- DKK -2,866,909
- Profit/Loss
- DKK -2,982,525
- Equity
- DKK 399,240
- Total Assets
- DKK 2,821,524
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -2.9 mio. | -3 mio. | 399 t. | - |
| 2023 | - | -1.6 mio. | -2.6 mio. | 3.4 mio. | - |
| 2022 | - | -2.9 mio. | -4.1 mio. | -7 mio. | - |
| 2021 | - | -2 mio. | -2.5 mio. | -2.9 mio. | - |
| 2020 | - | -2.5 mio. | -2.5 mio. | -360 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
As of August 21, 2024, Carsten Sylvester Larsen has joined the board of directors of Injecto A/S.
As of August 21, 2024, Thomas Sonne-Schmidt has left the board of directors of Injecto A/S.
Injecto A/S has published its annual report for 2023. Gross profit came to DKK -1,585,250, and the net result was DKK -2,626,586.
About Injecto A/S
Injecto A/S is a Danish company of the type Aktieselskab based in Hellerup, founded in 2017. The company is registered under the industry Fremstilling af medicinske og dentale instrumenter samt udstyr hertil. The company was previously named Lubrigone A/S. The management consists of Torben Helmer Knudsen. The board consists of John Holger Adamsen (chair), Carsten Sylvester Larsen and Torben Helmer Knudsen. The company is owned by Injecto Group A/S. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -2,590,948 and a net result of DKK -2,942,694 compared with DKK -2,982,525 the year before. Equity in the 2025 report amounted to DKK -43,454.